As a Senior Director in PPD Consulting, Patricia provides product development and global strategic regulatory advice to external and internal clients, determining the most appropriate strategy for their projects. She acts as a point of contact to provide regulatory and product development consulting advice and expertise to advanced therapy developers in a partnership setting and is a founder and leader of PPD’s Advanced Therapy cross-functional expert working group.
Since joining PPD’s in 2010 as a manager in global regulatory development, Dr. Hurley has successfully supported many clients with global clinical trial authorization applications, marketing authorization applications and strategic consulting discussions in several disease areas, including rare diseases. She has taken part in multiple regulatory agency interactions and scientific advice meetings with clients to discuss their cell and gene therapy product development.
She is based in the PPD Cambridge office in the UK, belongs to The Organization for Professionals in Regulatory Affairs (TOPRA) and sits on the editorial board of Regulatory Rapporteur. Prior to joining PPD, Dr. Hurley was head of project management and biomarkers division at a London-based regulatory and product development consulting group where she undertook the full range of global regulatory activities.
Dr. Hurley has a doctorate in molecular pharmacology and a bachelor’s in pharmacology and molecular genetics from University College Dublin, in Ireland.